Low-Level Laser and LED Therapy in Alopecia: A Systematic Review and Meta-Analysis
Authors:
- Sofia M. PerezSofia M. Perez
- Mounika VattiguntaMVMounika Vattigunta
- Colin KellyCKColin Kelly
- 15 October 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 51 (2) , 179-183
Abstract
BACKGROUND: Low-level laser/LED therapy (LLLT) has been described as a treatment option for alopecia, but no study has comprehensively reviewed its efficacy in multiple alopecia types. OBJECTIVE: To review and evaluate LLLT for various alopecia types. MATERIALS AND METHODS: A systematic search of PubMed/MEDLINE, Embase, and CENTRAL was conducted to identify studies assessing the effect of LLLT on patients diagnosed with alopecia. Prespecified outcome measure was the change in hair density. Meta-analysis was performed to calculate the standardized mean difference in hair density before and after LLLT compared with placebo. RESULTS: Thirty-eight studies were included that described 3,098 patients with androgenetic alopecia (2,930/3,098), scarring alopecia (49/3,098), alopecia areata (50/3,098), telogen effluvium (17/3,098), and chemotherapy-induced alopecia (32/3,098). The mean change in hair density increased significantly in androgenetic alopecia patients after LLLT for 4 to 26 weeks compared with placebo (20 weeks: SMD = 1.44; 95% CI [0.97–1.91]; p = .000; I2 = 80.81%). Change in hair density was reported in 5 studies evaluating other alopecia types; however, statistical information was insufficient for meta-analysis. CONCLUSION: LLLT is a promising treatment option for patients with androgenetic alopecia, but future studies are needed to better understand its efficacy in other alopecia types.Keywords
This publication has 47 references indexed in Scilit:
- The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial)Supportive Care in Cancer, 2023
- Efficacy of Minoxidil Combined With Photobiomodulation for the Treatment of Male Androgenetic Alopecia. A Double‐Blind Half‐Head Controlled TrialLasers in Surgery and Medicine, 2021
- Low‐Level Light Therapy Downregulates Scalp Inflammatory Biomarkers in Men With Androgenetic Alopecia and Boosts Minoxidil 2% to Bring a Sustainable Hair Regrowth ActivityLasers in Surgery and Medicine, 2021
- Comparison of low-level light therapy and combination therapy of 5% minoxidil in the treatment of female pattern hair lossLasers in Medical Science, 2020
- Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trialsLasers in Medical Science, 2019
- Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trialLasers in Medical Science, 2018
- Low level light‐minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: A randomized controlled studyLasers in Surgery and Medicine, 2017
- The growth of human scalp hair in females using visible red light laser and LED sourcesLasers in Surgery and Medicine, 2014
- The growth of human scalp hair mediated by visible red light laser and LED sources in malesLasers in Surgery and Medicine, 2013
- Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areataLasers in Medical Science, 2011